This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

First (1st) fit and driving

Authoring team

For the first unprovoked epileptic seizure/solitary fit:

Group 1 entitlement:

  • must not drive and must notify the DVLA
  • driving will be prohibited for 6 months from the date of the seizure. Clinical factors that indicate that there may be an increased risk of seizures require the DVLA not to consider licensing until after 12 months from the date of the first seizure

Group 2 entitlement:

  • must not drive and must notify the DVLA.
  • driving will be prohibited for 5 years from the date of the seizure. If, after 5 years, a neurologist has made a recent assessment and clinical factors or investigation results (for example, EEG or brain scan) indicate no annual risk greater than 2% of a further seizure, the licence may be restored
    • such licensing also requires that there has been no need for epilepsy medication throughout the 5 years up to the date of the licence being restored
  • if the prospective annual risk of further seizure is greater than 2%, the epilepsy regulations may apply

For more details contact the DVLA, consult the current issue of 'At a glance guide to the current medical standards of fitness to drive' or use the website www.dvla.gov.uk

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.